Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2010
12/23/2010US20100322944 Anti-bacterial antibodies
12/23/2010US20100322943 Therapeutic and diagnostic affinity purified specific polyclonal antibodies
12/23/2010US20100322942 Therapeutic and prophylactic methods for neuromuscular disorders
12/23/2010US20100322941 Human Anti-IP-10 Antibodies Uses Thereof
12/23/2010US20100322940 In vitro modification of glycosylation patterns of recombinant glycopeptides
12/23/2010US20100322939 Novel methods for treating egfr-associated tumors
12/23/2010US20100322938 Novel clusterin derived peptide
12/23/2010US20100322937 EGF receptor epitope peptides and uses thereof
12/23/2010US20100322936 Lm-1 antibodies, functional fragments, lm-1 target antigen, and methods for making and using same
12/23/2010US20100322935 Tri- or Tetraspecific Antibodies
12/23/2010US20100322934 Bispecific, Tetravalent Antigen Binding Proteins
12/23/2010US20100322933 Intraoperative trifunctional antibody application for prophylaxis of intraperitoneal tumor cell dissemination
12/23/2010US20100322932 Methods for amyloid removal using anti-amyloid antibodies
12/23/2010US20100322931 Anti-vegf antibodies and their uses
12/23/2010US20100322930 Fibronectin-based binding molecules and their use
12/23/2010US20100322929 Antigen presenting cell targeted cancer vaccines
12/23/2010US20100322928 Methods of diagnosing, monitoring treatment and treating systemic lupus erythematosus (sle)
12/23/2010US20100322927 Glycosylated antibodies
12/23/2010US20100322926 Methods of using cadherin 11 (cdh11) antagonists
12/23/2010US20100322925 Alk7 and myostatin inhibitors and uses thereof
12/23/2010US20100322924 Humanized Fc gamma RIIB-Specific Antibodies And Methods Of Use Thereof
12/23/2010US20100322923 Medical Uses of Glucans
12/23/2010US20100322922 Neutralization of CD95 Activity Blocks Invasion of glioblastoma Cells In Vivo
12/23/2010US20100322921 METHOD OF INHIBITING COAGULATION ACTIVATION WITH HUMAN ANTI-FACTOR Va ANTIBODIES AND USE THEREOF
12/23/2010US20100322920 Human monoclonal antibodies against CD30
12/23/2010US20100322919 Antibodies Against a Cancer-Associated Epitope of Variant NFKBIB and Uses Thereof
12/23/2010US20100322901 5, 6-ring annulated indole derivatives and use thereof
12/23/2010US20100322900 Treatment of multiple sclerosis with laquinimod
12/23/2010US20100322897 Characterization of il-17f and il-17r interactions
12/23/2010US20100322896 Molecular adjuvant
12/23/2010US20100322895 T cell depleting compositions useful for treating cancer
12/23/2010US20100322894 Combination Therapies for Treating Type 1 Diabetes
12/23/2010US20100322891 Immuniostimulating polyphosphazene compounds
12/23/2010US20100322872 Novel methods and medicament for treating infectious diseases involving microbial biofilms
12/23/2010US20100322863 Methods and Uses of Anti-IL-23 Antibodies
12/23/2010US20100322862 Methods and compositions using peptides and proteins with c-terminal elements
12/23/2010US20100322853 Nanoparticulate compositions of angiogenesis inhibitors
12/23/2010US20100322852 Nanoparticulate compositions of angiogenesis inhibitors
12/23/2010US20100322851 KID3 and KID3 Antibodies That Bind Thereto
12/23/2010US20100322849 Enhanced b cell cytotoxicity of cdim binding antibody
12/23/2010CA2765801A1 Hla-g alpha 1 multimers and pharmaceutical uses thereof
12/23/2010CA2765799A1 System for the heterologous expression of a viral protein in a ciliate host cell
12/23/2010CA2765755A1 Anti-vegf antibodies and their uses
12/23/2010CA2765511A1 Nanoemulsion vaccines
12/23/2010CA2765448A1 Stimulation of innate immunity with an antigen from bacterial origin
12/23/2010CA2765364A1 Influenza vaccine, composition, and methods of use
12/23/2010CA2764545A1 Bace1 inhibitory antibodies
12/23/2010CA2761568A1 Structured viral peptide compositions and methods of use
12/22/2010EP2264187A1 Method for diagnosing non-small cell lung cancers
12/22/2010EP2264186A1 Method for diagnosing non-small cell lung cancers
12/22/2010EP2264185A1 Method for diagnosing non-small cell lung cancers
12/22/2010EP2264178A1 Vaccinia virus host range genes to increase the titer of Avipoxviruses
12/22/2010EP2264176A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/22/2010EP2264166A2 Method for controlling the activity of immunologically functional molecule
12/22/2010EP2264162A1 Stable aqueous systems comprising proteins
12/22/2010EP2264161A1 Stable aqueous systems comprising proteins
12/22/2010EP2264073A1 Endothelial cell specific antibodies and uses thereof
12/22/2010EP2264072A1 Enhancement of antibody-mediated cytotoxicity.
12/22/2010EP2264071A1 Antibody having an immune-enhancement function
12/22/2010EP2264070A1 Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-CD20 antibody
12/22/2010EP2264067A1 HLA-G alpha 1 multimers and pharmaceutical uses thereof
12/22/2010EP2264059A1 Polypeptides, cDNAs encoding the same and utilization thereof
12/22/2010EP2264057A1 Recombinant antigen
12/22/2010EP2264050A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263697A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/22/2010EP2263693A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
12/22/2010EP2263692A1 Anti-NGF antibodies and methods using same
12/22/2010EP2263691A1 Treatment of cancer with the recombinant humanized monoclonal anti-erbb2 antibody 2C4 (rhuMAb 2C4)
12/22/2010EP2263690A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263689A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263688A1 Neisseria meningitidis combination vaccines
12/22/2010EP2263687A1 Immunogenic compositions containing phospholipid
12/22/2010EP2263686A1 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments
12/22/2010EP2263465A1 Polyvalent conjugate vaccine for cancer
12/22/2010EP2262839A1 Use of an anti-cd151 antibody for early treatment of cancer
12/22/2010EP2262838A1 Agent for treating disease
12/22/2010EP2262834A2 Antibodies as t cell receptor mimics, methods of production and uses thereof
12/22/2010EP2262833A1 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions
12/22/2010EP2262828A1 Compositions, methods and kits
12/22/2010EP2262541A1 C2orf18 as target gene for cancer therapy and diagnosis
12/22/2010EP2262533A1 Screening method for agents suitable for prophylaxis and therapy of alzheimer's disease (ad)
12/22/2010EP2262532A1 The calcium sensor STIM1 and the platelet SOC channel Orai1 (CRACM1) are essential for pathological thrombus formation
12/22/2010EP2262531A1 Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
12/22/2010EP2262530A1 Metalloproteinase 12 binding proteins
12/22/2010EP2262529A2 Metalloproteinase 9 binding proteins
12/22/2010EP2262528A2 Sphingosine 1-phosphate antagonism
12/22/2010EP2262526A1 Stable amyloid beta monomers and oligomers
12/22/2010EP2262511A2 Methods for inducing the differentiation of blood monocytes into functional dendritic cells
12/22/2010EP2262494A2 Inhibition of post-radiation tumor growth by an inhibitor of vasculogenesis
12/22/2010EP2262480A1 Immunomodulator particles and methods of treating
12/22/2010EP2164516B1 Optimized dna and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins
12/22/2010EP2004688B1 Improved protofibril selective antibodies and the use thereof
12/22/2010EP1993595B1 Tumour vaccine comprising allogeneic or xenogeneic tumour cells
12/22/2010EP1848456B1 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
12/22/2010EP1838345B1 Saccharide conjugate vaccines
12/22/2010EP1824886B1 Fully human monoclonal antibodies to il-13
12/22/2010EP1730196B1 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
12/22/2010EP1676862B1 Recombinant antibody against human insulin-like growth factor
12/22/2010EP1549338B1 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
12/22/2010EP1364660B1 Drug-releasing system of biodegradable polymer type
1 ... 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 ... 1823